A new cell-permeable calpain inhibitor

Journal of Peptide Science

Volumn 13, Issue 1, 2007, Pages 70-73

  Fiorino, Ferdinando ^a,c   Gil Parrado, Shirley ^a,d   Assfalg Machleidt, Irmgard ^b   Machleidt, Werner ^b   Moroder, Luis ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Calpains; Cellular uptake; Penetratin; Peptide inhibitors

Indexed keywords

CALPAIN; CALPASTATIN; CATHEPSIN L; PENETRATIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TRANSPORT KINETICS;

ANIMALIA;

EID: 33846677107     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.790     Document Type: Article

References (18)

1. Vanderklish PW, Bahr BA. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 2000; 81: 323-339.
2. Huang Y, Wang KK. The calpain family and human diseases. Trends Mol. Med. 2001; 7: 355-362.
3. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem. J. 1997; 328: 721-732.
4. Wang KK, Yuen PW. Development and therapeutic potential of calpain inhibitors. Adv. Pharmacol. 1997; 37: 117-152.
5. Maki M, Takano E, Osawa T, Ooi T, Murachi T, Hatanaka M. Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli. J. Biol. Chem. 1988; 263: 10254-10261.
6. Maki M, Bagci H, Hamaguchi K, Ueda M, Murachi T, Hatanaka M. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J. Biol. Chem. 1989; 264: 18866-18869.
7. Eto A, Akita Y, Saiso TC, Suzuki K, Kawashima S. The role of the calpain-calpastin system in tyrotropin-releasing hormone-induced selective down-regulation of a protein kinase C isoenzyme, nPKCε, in rat pituitary GH4Cl cells. J. Biol. Chem. 1995; 270: 25115-25120.
8. Gonscherowski V, Becker BF, Moroder L, Motrescu E, Gil-Parrado S, Gloe T, Keller M, Zahler S. Calpains: a physiological regulator of the endothelial barrier? Am. J. Physiol. Heart Circ. Physiol. 2006; 290: H2035-H2042.
9. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994; 269: 10444-10450.
10. Derossi D, Chassaing G, Prochiantz A. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 1998; 8: 84-87.
11. Fischer PM, Krausz E, Lane DP. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation, Bioconjug. Chem. 2001; 12: 825-841.
12. Snyder EL, Dowdy SF. Cell-penetrating peptides in drug delivery. Pharm. Res. 2004: 21: 389-393.
13. Temsamani J, Vidal P. The use of cell-penetrating peptides for drug delivery. Drug Discov. Today 2004; 9: 1012-1019.
14. Gil-Parrado S, Assfalg-Machleidt I, Fiorino F, Deluca D, Pfeiler D, Schaschke N, Moroder L, Machleidt W. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin. Biol. Chem. 2003; 384: 395-402.
15. Fischer PM, Zhelev ZN, Wang S, Melville JE, Fåhraeus R, Lane DP. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector penetratin. J. Pept. Res. 2000; 55: 163-172.
16. Schaschke N, Deluca D, Assfalg-Machleidt I, Höhneke C, Sommerhoff CP, Machleidt W. Epoxysuccinyl peptide-derived cathepsin B inhibitors. Modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin. Biol. Chem. 2002; 383: 849-852.
17. Bepler G, Koehler A, Kiefer P, Havermann K, Beisenherz K, Jaques G, Gropp C, Haeder M. Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines. Differentiation 1988; 37: 158-171.
18. Gabrijelcic-Geiger D, Mentele R, Meisel B, Hinz H, Assfalg-Machleidt I, Machleidt W, Möller A, Auerswald EA. Human μ-calpain: simple isolation from erythrocytes and characterization of autolysis fragments. Biol. Chem. 2001; 382: 1733-1737.